Discrepant findings in immune responses to JC virus in patients receiving natalizumab
暂无分享，去创建一个
R. Kinkel | I. Koralnik | R. Viscidi | C. Tan | Marion C Stein | Yiping Chen | Marion C. Stein | Raphael P. Viscidi | R. Kinkel | Chen S. Tan
[1] R. Ransohoff. PML risk and natalizumab: more questions than answers , 2010, The Lancet Neurology.
[2] G. Pantaleo,et al. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study , 2010, The Lancet Neurology.
[3] A. Sandrock,et al. Asymptomatic reactivation of JC virus in patients treated with natalizumab. , 2009, The New England journal of medicine.
[4] J. Schmitz,et al. Detection of JC Virus-Specific Cytotoxic T Lymphocytes in Healthy Individuals , 2004, Journal of Virology.
[5] M. Kuroda,et al. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. , 2004, Brain : a journal of neurology.